MedTrace Logo

Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

NCT05302531 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-08-29

No results posted yet for this study

Summary

The purpose of this study is to assess the drug absorption of oral antibiotics in patients with short bowel syndrome.

Conditions

  • Short Bowel Syndrome
  • Infection, Bacterial

Interventions

DRUG

Amoxicillin

Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally

DRUG

Levofloxacin

Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally

DRUG

Ofloxacin

Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally

DRUG

Sulfamethoxazole trimethoprim

Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally

Sponsors & Collaborators

  • Société Francophone Nutrition Clinique et Métabolisme

    collaborator OTHER

  • FIlière des Maladies rares Abdomino-THOraciques

    collaborator UNKNOWN

  • Fresenius Kabi

    collaborator INDUSTRY

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Niasha MICHOT, MD · CHRU Nancy

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-09
Primary Completion
2024-12-31
Completion
2025-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05302531 on ClinicalTrials.gov